Photo taken from Phillip Febbo/LinkedIn.
Sep 28, 2023, 18:28
Phillip G. Febbo: I am super excited to move back closer to patient testing and to take on the role of Chief Science Officer and Chief Medical Officer at Veracyte.
Quoting Phillip G. Febbo, Board Member and Chair or Governance Committee at the Reagan-Udall Foundation for the FDA, on LinkedIn:
“I am super excited to move back closer to patient testing and to take on the role of Chief Science Officer and Chief Medical Officer at Veracyte. A broader role with a more defined focus on improving cancer patient management and outcomes. Looking forward to getting back to direct impact on patient care, healthcare, and a thriving business in today’s environment!”
Source: Phillip G. Febbo/LinkedIn.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 13:07
Apr 18, 2025, 12:54
Apr 18, 2025, 12:14
Apr 18, 2025, 11:51
Apr 18, 2025, 11:18
Apr 18, 2025, 10:55